Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BAMLANIVIMAB vs BEBTELOVIMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

BAMLANIVIMAB vs BEBTELOVIMAB: Safety Overview

Metric BAMLANIVIMAB BEBTELOVIMAB
Total FAERS Reports 5,280 1,383
Deaths Reported 307 20
Death Rate 5.8% 1.4%
Hospitalizations 2,175 224
Average Patient Age 63.6 yrs 56.4 yrs
% Female Patients 50.5% 66.9%